Swift Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Swift Biosciences's estimated annual revenue is currently $2.6M per year.
- Swift Biosciences received $12.2M in venture funding in July 2017.
- Swift Biosciences's estimated revenue per employee is $77,500
- Swift Biosciences's total funding is $31.2M.
Employee Data
- Swift Biosciences has 34 Employees.
- Swift Biosciences grew their employee count by -56% last year.
Swift Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.9M | 12 | 0% | N/A | N/A |
#2 | $2.6M | 34 | -56% | $31.2M | N/A |
#3 | $0.8M | 5 | -44% | N/A | N/A |
#4 | $1.9M | 24 | 100% | N/A | N/A |
#5 | $6M | 39 | -11% | N/A | N/A |
#6 | $4M | 26 | -33% | N/A | N/A |
#7 | $1.9M | 12 | 0% | N/A | N/A |
#8 | $0.8M | 5 | 25% | N/A | N/A |
#9 | $14.6M | 94 | 8% | N/A | N/A |
#10 | $3.4M | 22 | 5% | N/A | N/A |
What Is Swift Biosciences?
Swift Biosciences specializes in sample preparation for next-generation sequencing (NGS). We are an energetic, highly innovative company focused on creating better tools to empower NGS technologies and deliver superior science. Our products are designed to help customers analyze samples faster, easier, and with greater sensitivity and accuracy while being compatible with leading instrumentation. Swift's powerful team of scientists and executives have a strong track record of joining discovery with function. Our product development is purposeful and focused on creating products that are well-regarded by both customers and multiple industries, such as the agrigenomics, pharmaceutical, academic, biotechnology, and oncology research fields. The company was created with the support of experienced life science investors and opened its doors in 2014. Our multiple innovation platforms have been developed by our growing team of talented scientists and are covered by a unique portfolio of intellectual property. Please visit our website for more information.
keywords:N/A
$31.2M
Total Funding
34
Number of Employees
$2.6M
Revenue (est)
-56%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Swift Biosciences News
He previously served as interim CEO at Swift Biosciences, an NGS library prep provider in 2017 and 2018, and as a board member from 2017...
2020. Sensitive recovery of complete SARS-CoV-2 genomes from clinical samples by use of swift biosciences' SARS-CoV-2 multiplex amplicon...
ANN ARBOR, Mich., June 7, 2021 /PRNewswire/ -- Swift Biosciences, pioneers in the development of library preparation and targeted sequencing solutions for next generation sequencing (NGS) in research applications, has announced the release of Swift 2S™ Turbo v2 DNA Library Kits for whole genom ...
Other Companies in Ann Arbor
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6.2M | 34 | 6% | N/A |
#2 | $7.3M | 34 | 0% | N/A |
#3 | $5.5M | 34 | N/A | N/A |
#4 | $3.3M | 34 | -6% | N/A |
#5 | $1.7M | 34 | 6% | N/A |
Swift Biosciences Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2013-10-18 | $7.0M | B | Fletcher Spaght Ventures | Article |
| 2016-05-02 | $3.3M | Undisclosed | Article | |
| 2017-07-03 | $12.2M | D | Arboretum Ventures | Article |